Innovation in human biology is evolving at breakneck speed. Artificial intelligence, data science and pharmaceutical discoveries - combined with a deeper understanding of how the body works at a cellular level - are creating exciting opportunities to extend health span.
Dr. Ron Alfa is Senior Vice President of Discovery & Product at Recursion a clinical-stage biotechnology company, recently named by Fast Company as one the World’s Most Innovative Companies for 2019.
In this LLAMA podcast interview, with Peter Bowes, Dr, Alfa explains Recursion’s mission to create a map of human cellular biology and find novel treatment for the diseases of aging. This interview was recorded at TEDMED